Lead Research Specialist
- Led cross-functional R&D collaboration applied to pediatric hematologic malignancies, resulting in 2 first-author publications on combination therapy strategies.- Developed cost-effective high-throughput screening platform (ELISA) for kinase inhibitor discovery, saving in capital equipment costs while maintaining data quality.